Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours
This study has been completed.
Study NCT00607958
Information provided by Germans Trias i Pujol Hospital
First Received on January 23, 2008.
Last Updated on July 14, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
